BrillianceTube: Market Launch of Decorated Packaging
Sanner GmbH, a manufacturer of high-quality plastic packaging for pharmaceutical, medical and healthcare products, is expanding its portfolio. The new BrillianceTube for effervescent tablets with in-mold labeling (IML) and the proven desiccant closures offers customers a complete solution.
Photorealistic printing and more legible product information are some of the advantages of the newly launched BrillianceTube packaging from Sanner GmbH. Combined with proven Sanner desiccant closures, the tubes are best suited for effervescent tablets, but also work with conventional or coated tablets and other solid pharmaceutical products. Manufactured using IML technology, the packaging offers customers a wide range of design options and a premium-quality appearance. BrillianceTubes combined with proven Sanner desiccant closures protect their contents perfectly against light and moisture.
The advantage of IML technology is that packaging production and decoration are combined into a single process. Printed labels are placed in the mold and the liquid plastic is injected. The temperature of the plastic causes the label to fully bond with the tube. Additionally the geometry of the tube base ensures that the tubes can be easily packaged in standard commercial sales trays.
Expansion of Effervescent Packaging Product Range
"The development of Brilliance underscores our leadership position in the field of effervescent packaging. It is especially important for us to support our customers as a system supplier across the entire supply chain," explained Sanner CEO Holger Frank. This includes the systematic development of efficient logistical solutions. Sanner customers get everything from a single source: from printed labels and the manufacturing of decorated tubes up to delivery. "Our customers can always rely on proven Sanner quality. In addition, having a centrally-located contact reduces organizational effort,” Frank emphasized. "Our customers can efficiently purchase their decorated tubes with different fitting types of closures. Thus, Brilliance enables us to meet customer demands with more flexibility."
More Attention at the Point of Sale
Unlike conventional printed packaging, tubes manufactured using the IML technology offer high quality, photorealistic printing with a choice of textures and finishes. Up to eight colours and metallic effects are possible to make packaging stand out at the point of sale. Labels that are easy to read with smaller font sizes provide more space for important product information. The high-impact, scratch-resistant material is extremely durable. Using modern communication media such as integrated QR codes makes it easier for customers to access additional information about the manufacturer and product.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance